Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.1800 (-4.78%) ($6.1400 - $6.5400) on Wed. Aug. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.48% (three month average) | RSI | 41 | Latest Price | $6.1800(-4.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.6% a day on average for past five trading days. | Weekly Trend | CAPR declines -10.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) TLT(26%) IGOV(25%) VCIT(20%) TIP(16%) LQD(6%) | Factors Impacting CAPR price | CAPR will decline at least -4.24% in a week (0% probabilities). URA(-36%) XLB(-33%) PAVE(-27%) XOP(-25%) OIH(-25%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.24% (StdDev 8.48%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $7.28 | 5 Day Moving Average | $6.34(-2.52%) | 10 Day Moving Average | $6.47(-4.48%) | 20 Day Moving Average | $7.28(-15.11%) | To recent high | -37% | To recent low | 23.4% | Market Cap | $122m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |